Delivery Order SPE2DB24D9131-SPE2DB25FXRU0

DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $2,016 delivery order by the Defense Logistics Agency on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract calls for the supply of IOSAT 130 mg tablets in quantities of 14, using firm fixed-price pricing with no set-aside designation. The delivery order is performed at the contractor's Park Ridge, Illinois location and represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA.

This delivery order is issued under DMS Pharmaceutical Group's significant single-award IDC with the Defense Logistics Agency valued at $499.999 billion through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting the medical supply needs of military health facilities worldwide. The parent IDC covers an extensive portfolio including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple product categories. As an established pharmaceutical wholesaler with more than two decades of federal contracting experience, DMS Pharmaceutical Group serves as a critical supplier within the Defense Department's pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.